# Kestra Medical Technologies, Ltd. (KMTS)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/kestra-medical-technologies-ltd/ JSON: https://steadybase.io/company/kestra-medical-technologies-ltd.json Checked Nov 10, 2026. Latest filing read: Sep 14, 2026.

## Company

- Legal name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- Ticker: KMTS (Nasdaq)
- SEC CIK: 0001877184
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Kirkland, WA
- Fiscal year ends: April 30
- SEC filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Website: kestramedical.com
- Investor relations: https://investors.kestramedical.com/news-events/news-releases
- LinkedIn: https://www.linkedin.com/company/kestra-medical-technologies-inc.
- Next earnings date: Dec 10, 2026

## Key facts

- Revenue: $95.1M for the fiscal year ended Apr 30, 2026 (10-K filed Jul 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/0001193125-26-303397-index.html
- Operating income: -$134.7M for the fiscal year ended Apr 30, 2026 (10-K filed Jul 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/0001193125-26-303397-index.html
- Net income: -$131.6M for the fiscal year ended Apr 30, 2026 (10-K filed Jul 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/0001193125-26-303397-index.html
- SG&A: $164.1M for the fiscal year ended Apr 30, 2026 (10-K filed Jul 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/0001193125-26-303397-index.html
- Employees: 443 as of Apr 30, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/ck0001877184-20260430.htm
- Shares outstanding: 59,561,795 as of Sep 11, 2026 (10-Q filed Sep 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390766/0001193125-26-390766-index.html
- Auditor: Pricewaterhousecoopers LLP, Irvine, California, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/ck0001877184-20260430.htm

## Business

We are a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. We have developed and are commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (“SCA”) during vulnerable periods of recovery.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/ck0001877184-20260430.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Apr 30, 2026 | $95.1M | -$134.7M | -$131.6M | $164.1M |
| Apr 30, 2025 | $59.8M | -$106.4M | -$113.8M | $114.9M |
| Apr 30, 2024 | $27.8M | -$85.1M | -$94.1M | $69.9M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/kestra-medical-technologies-ltd.json

## Officers and directors

- Brian Webster, President and Chief Executive Officer. LinkedIn: https://linkedin.com/in/brian-webster-b67b435. Source: 10-Q filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/1877184/000119312526390766/ck0001877184-ex31_1.htm
- Vaseem Mahboob, Chief Financial Officer. LinkedIn: https://linkedin.com/in/vaseem-mahboob-6a397a11. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1877184/000119312526345169/0001193125-26-345169-index.htm
- Alfred J. Ford Jr, Chief Commercial Officer. Source: Form 4 filed Aug 6, 2026, https://www.sec.gov/Archives/edgar/data/1877184/000119312526338668/0001193125-26-338668-index.htm
- Timothy P. Moran, Chief Business Officer. Source: Form 4 filed Aug 3, 2026, https://www.sec.gov/Archives/edgar/data/1877184/000119312526331066/0001193125-26-331066-index.htm

## Recent 8-K events

- Sep 14, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390535/ck0001877184-20260914.htm
- Sep 10, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388057/ck0001877184-20260909.htm
- Jul 14, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.02, Results of operations and financial condition (earnings release); Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303169/ck0001877184-20260710.htm
- Mar 17, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526110720/ck0001877184-20260317.htm
- Dec 11, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312525315896/ck0001877184-20251211.htm
- Dec 4, 2025: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312525308144/d92377d8k.htm
- Dec 1, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312525303104/d944376d8k.htm
- Nov 10, 2025: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312525274183/ck0001877184-20251110.htm
- Sep 11, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1877184/000095017025114228/ck0001877184-20250911.htm
- Sep 4, 2025: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1877184/000095017025113058/ck0001877184-20250903.htm

## Insider trades (Form 4)

- Nov 3, 2026: Timothy P. Moran (Chief Business Officer) sold 3,192 shares, about $94,352. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526450260/0001193125-26-450260-index.htm
- Oct 29, 2026: Vaseem Mahboob (Chief Financial Officer) sold 79,500 shares, about $2.4M. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526438722/0001193125-26-438722-index.htm
- Oct 27, 2026: Traci S. Umberger (See Remarks) sold 30,000 shares, about $900,882. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526438662/0001193125-26-438662-index.htm
- Oct 21, 2026: Traci S. Umberger (See Remarks) sold 100,000 shares, about $2.7M. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526428980/0001193125-26-428980-index.htm
- Oct 20, 2026: Brian Daniel Webster (See Remarks) sold 15,000 shares, about $443,389. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526428976/0001193125-26-428976-index.htm
- Sep 30, 2026: Raymond W. Cohen (Director) sold 3,330 shares, about $97,504. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526410928/0001193125-26-410928-index.htm
- Sep 21, 2026: Elizabeth Kwo (Director) sold 4,010 shares, about $97,283. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526399696/0001193125-26-399696-index.htm
- Sep 8, 2026: Conor Hanley (Director) sold 5,694 shares, about $143,774. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388302/0001193125-26-388302-index.htm
- Sep 8, 2026: Kevin C. Reilly (Director) sold 2,932 shares, about $73,681. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388298/0001193125-26-388298-index.htm
- Sep 8, 2026: Mary Kay Ladone (Director) sold 3,908 shares, about $98,482. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388297/0001193125-26-388297-index.htm
- Sep 8, 2026: Jeffrey Lawrence Schwartz (Director) sold 3,890 shares, about $97,950. Source: https://www.sec.gov/Archives/edgar/data/1877184/000095013026000223/0000950130-26-000223-index.htm
- Aug 17, 2026: Brian Daniel Webster (See Remarks) sold 15,000 shares, about $412,200. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526355847/0001193125-26-355847-index.htm
- Aug 7, 2026: Vaseem Mahboob (Chief Financial Officer) sold 26,287 shares, about $680,275. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526345169/0001193125-26-345169-index.htm
- Aug 4, 2026: Alfred J. Ford Jr (Chief Commercial Officer) sold 6,275 shares, about $151,165. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526338668/0001193125-26-338668-index.htm
- Aug 4, 2026: Vaseem Mahboob (Chief Financial Officer) sold 6,995 shares, about $172,645. Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526338665/0001193125-26-338665-index.htm

## What management said

- "Kestra delivered another strong quarter of financial performance, generating revenue growth of 60% while expanding gross margin to over 56%" Brian Webster, President and CEO (8-K filed Sep 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390535/ck0001877184-ex99_1.htm

## Latest filings

- 8-K filed Sep 14, 2026: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390535/ck0001877184-20260914.htm
- 10-K filed Jul 14, 2026: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303397/ck0001877184-20260430.htm
- 10-Q filed Sep 14, 2026: https://www.sec.gov/Archives/edgar/data/1877184/000119312526390766/ck0001877184-20260731.htm
- DEF 14A filed Jul 28, 2026: https://www.sec.gov/Archives/edgar/data/1877184/000119312526320956/ck0001877184-20260727.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/